Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|August 23, 2021
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized TrialGavin Churchyard, Vicky Cárdenas, Violet Chihota, et al.
The Lancet. Infectious Diseases|May 17, 2011
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda E Gray, Mary Allen, Zoe Moodie, et al.
The Journal of Infectious Diseases|March 17, 2026
Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countriesBelén Saavedra-Cervera, Dinis Nguenha, Violet Chihota, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary TuberculosisElin M Svensson, Robin J Svensson, Lindsey H M Te Brake, et al.
The Pediatric Infectious Disease Journal|March 3, 2022
High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant TuberculosisSoyeon Kim, Xingye Wu, Michael D Hughes, et al.
Plos One|September 2, 2016
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African ParticipantsGavin Churchyard, Koleka Mlisana, Shelly Karuna, et al.
Msphere|June 13, 2022
Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay ConversionJason D Simmons, Kimberly A Dill-McFarland, Catherine M Stein, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The New England Journal of Medicine|June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosisAndreas H Diacon, Alexander Pym, Martin Grobusch, et al.
Pageof 14